Alessandro Fiocchi

Alessandro Fiocchi MD is the Director of Allergy at the Pediatric Hospital Bambino Gesù, Rome, Vatican City. Formerly director of Paediatrics at the Melloni University Hospital in Milan, Italy, he’s an expert in the field of food allergy. After post-graduate degrees and professional qualification in paediatrics, allergy, pulmonology, and neonatology, he dedicated his research and clinical work to the care of children with asthma and allergic disease. Currently, he leads a research group focusing on food allergy, asthma, and specific immunotherapy. This group is based in the Bambino Gesù Pediatric Hospital (OPBG) a health care and research institution specialised in paediatric and developing ages. The largest Pediatric Hospital in Italy, OPBG guarantees total coverage for all health care needs, including allergy. Since 2001, he has organized international meetings in Milan, Italy, and other countries. He has founded and presides over the Italian Research Foundation for Allergy and Asthma in Childhood – Allegria ONLUS, a charity dedicated to clinical and research studies. As chair of the Adverse Reactions to Foods Committee of the American College of Allergy, Asthma, and Immunology, he co-chaired with Sami Bahna and Amal Assa’ad several International Food Allergy Symposiums, the last in Anaheim, November 2012. He also co-chaired with Hugh Sampson the WAO Food Allergy Symposium in Bangkok, 2007, and in Buenos Aires, 2009. Starting in January 2008, Dr. Fiocchi is the chair of the Special Committee on Food Allergy of the World Allergy Organization. Under his chairmanship, WAO published the DRACMA guidelines on cow’s milk allergy in 2010 and the CUPPA position paper on the use of probiotics in pediatric allergy. He’s also the leader of the WAO – supported GLAD-p (GuideLinesfor Allergy Prevention) project, which published three guidelines so far (Probiotics, 2015; Prebiotics, 2016; Vitamin D, 2017). DRACMA will be re-edited in 2021. His publications cover the fields of food allergy diagnosis, follow-up, epidemiology, specific immunotherapy and childhood asthma.